Global mRNA Vaccines & Therapeutics Market Analysis 2013-2018 and Forecast 2019-2024

  • Report Code : AMP136210
  • Published : Apr, 2019
  • Category : Healthcare & Pharma
  • Publisher : 99Strategy
  • Pages : 97
Overview

Ample Market Research published a report, titled, "Global mRNA Vaccines & Therapeutics Market Analysis 2013-2018 and Forecast 2019-2024". The study provides insights on the present scenario as well as the growth prospects of the “Global mRNA Vaccines & Therapeutics Market Analysis 2013-2018 and Forecast 2019-2024”. It presents the qualitative and quantitative analysis of the industry by analyzing the current trends, market growth drivers, restraints, opportunities, and various marketing strategies adopted by the players.

  • The global mRNA Vaccines & Therapeutics market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of mRNA Vaccines & Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Standardization Of Cancer Treatment MRNA Vaccine

    Individualized Cancer Treatment MRNA Vaccine

    Infectious Disease Treatment MRNA Vaccine

    Infection Prevention MRNA Vaccine

    Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

    Argos Therapeutics

    AstraZeneca

    Bayer

    BioNTech

    Boehringer Ingelheim

    CRISPR Therapeutics

    CureVac

    eTheRNA immunotherapies

    Ethris

    GlaxoSmithKline Vaccines

    In-Cell-Art

    Intellia Therapeutics

    Janssen

    Kernal Biologics

    MaxCyte

    Moderna Therapeutics

    Novartis

    PhaseRx

    Precision NanoSystems

    RaNa Therapeutics

    Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

    Hospital

    Clinic

    Others

    Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

    North America (U.S., Canada, Mexico)

    Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

    Asia-Pacific (China, India, Japan, Southeast Asia etc.)

    South America (Brazil, Argentina etc.)

    Middle East & Africa (Saudi Arabia, South Africa etc.)

     

  • Table of Contents

    1 Industry Overview

    1.1 mRNA Vaccines & Therapeutics Industry

    1.1.1 Overview

    1.1.2 Development of mRNA Vaccines & Therapeutics

    1.2 Market Segment

    1.2.1 Upstream

    1.2.2 Downstream

    1.3 Cost Analysis

    2 Industry Environment (PEST Analysis)

    2.1 Policy

    2.2 Economics

    2.3 Sociology

    2.4 Technology

    3 mRNA Vaccines & Therapeutics Market by Type

    3.1 By Type

    3.1.1 Standardization Of Cancer Treatment MRNA Vaccine

    3.1.2 Individualized Cancer Treatment MRNA Vaccine

    3.1.3 Infectious Disease Treatment MRNA Vaccine

    3.1.4 Infection Prevention MRNA Vaccine

    3.2 Market Size

    3.3 Market Forecast

    4 Major Companies List

    4.mRNA Vaccines & Therapeutics Argos Therapeutics (Company Profile, Sales Data etc.)

    4.2 AstraZeneca (Company Profile, Sales Data etc.)

    4.3 Bayer (Company Profile, Sales Data etc.)

    4.4 BioNTech (Company Profile, Sales Data etc.)

    4.5 Boehringer Ingelheim (Company Profile, Sales Data etc.)

    4.6 CRISPR Therapeutics (Company Profile, Sales Data etc.)

    4.7 CureVac (Company Profile, Sales Data etc.)

    4.8 eTheRNA immunotherapies (Company Profile, Sales Data etc.)

    4.9 Ethris (Company Profile, Sales Data etc.)

    4.10 GlaxoSmithKline Vaccines (Company Profile, Sales Data etc.)

    4.11 In-Cell-Art (Company Profile, Sales Data etc.)

    4.12 Intellia Therapeutics (Company Profile, Sales Data etc.)

    4.13 Janssen (Company Profile, Sales Data etc.)

    4.14 Kernal Biologics (Company Profile, Sales Data etc.)

    4.15 MaxCyte (Company Profile, Sales Data etc.)

    4.16 Moderna Therapeutics (Company Profile, Sales Data etc.)

    4.17 Novartis (Company Profile, Sales Data etc.)

    4.18 PhaseRx (Company Profile, Sales Data etc.)

    4.19 Precision NanoSystems (Company Profile, Sales Data etc.)

    4.20 RaNa Therapeutics (Company Profile, Sales Data etc.)

    5 Market Competition

    5.1 Company Competition

    5.2 Regional Market by Company

    6 Demand by End Market

    6.1 Demand Situation

    6.1.1 Demand in Hospital

    6.1.2 Demand in Clinic

    6.1.3 Demand in Others

    6.2 Regional Demand Comparison

    6.3 Demand Forecast

    7 Region Operation

    7.1 Regional Production

    7.2 Regional Market

    7.3 by Region

    7.3.1 North America

    7.3.1.1 Overview

    7.3.1.2 by Country (U.S., Canada, Mexico)

    7.3.2 Europe

    7.3.2.1 Overview

    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

    7.3.3 Asia-Pacific

    7.3.3.1 Overview

    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

    7.3.4 South America

    7.3.4.1 Overview

    7.3.4.2 by Country (Brazil, Argentina etc.)

    7.3.5 Middle East & Africa

    7.3.5.1 Overview

    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

    7.4 Regional Import & Export

    7.5 Regional Forecast

    8 Marketing & Price

    8.1 Price and Margin

    8.1.1 Price Trends

    8.1.2 Factors of Price Change

    8.1.3 Manufacturers Gross Margin Analysis

    8.2 Marketing Channel

    9 Research Conclusion

     

This is a single user license, allowing one specific user access to the product.

This is a site license, allowing all users within a given geographical location of your organisation access to the product.

This is an enterprise license, allowing all employees within your organisation access to the product.

The report will sent to you in PDF format via email.

Need Assistance ?